Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease.

Fiedler J, Park DH, Hobuß L, Anaraki PK, Pfanne A, Just A, Mitzka S, Dumler I, Weidemann F, Hilfiker A, Thum T.

J Cardiovasc Transl Res. 2019 Mar 6. doi: 10.1007/s12265-019-09880-7. [Epub ahead of print]

PMID:
30840186
2.

Mid- to Long-term Outcomes After Split-thickness Skin Graft vs. Skin Extension by Multiple Incisions.

Kern JN, Weidemann F, O'Loughlin PF, Krettek C, Gaulke R.

In Vivo. 2019 Mar-Apr;33(2):453-464. doi: 10.21873/invivo.11494.

3.

Dyshidrosis is associated with reduced amplitudes in electrically evoked pain-related potentials in women with Fabry disease.

Siedler G, Káhn AK, Weidemann F, Wanner C, Sommer C, Üçeyler N.

Clin Neurophysiol. 2019 Apr;130(4):528-536. doi: 10.1016/j.clinph.2019.01.008. Epub 2019 Feb 4.

PMID:
30785009
4.

Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.

Weidemann F, Beer M, Kralewski M, Siwy J, Kampmann C.

Mol Genet Metab. 2019 Feb;126(2):169-182. doi: 10.1016/j.ymgme.2018.11.005. Epub 2018 Nov 12.

5.

Fabry Disease: Cardiomyopathy Staging.

Weidemann F, Reiser M.

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1684-1685. doi: 10.1016/j.jcmg.2018.05.029. Epub 2018 Dec 12. No abstract available.

PMID:
30553671
6.

Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis.

Salinger T, Hu K, Liu D, Taleh S, Herrmann S, Oder D, Gensler D, Müntze J, Ertl G, Lorenz K, Frantz S, Weidemann F, Nordbeck P.

Cardiol Res Pract. 2018 Nov 11;2018:3713897. doi: 10.1155/2018/3713897. eCollection 2018.

7.

The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.

Germain DP, Arad M, Burlina A, Elliott PM, Falissard B, Feldt-Rasmussen U, Hilz MJ, Hughes DA, Ortiz A, Wanner C, Weidemann F, Spada M.

Mol Genet Metab. 2019 Mar;126(3):224-235. doi: 10.1016/j.ymgme.2018.09.007. Epub 2018 Sep 27. Review.

8.

Myocardial Fibrosis Predicts 10-Year Survival in Patients Undergoing Aortic Valve Replacement.

Herrmann S, Fries B, Salinger T, Liu D, Hu K, Gensler D, Strotmann J, Christa M, Beer M, Gattenlöhner S, Störk S, Voelker W, Bening C, Lorenz K, Leyh R, Frantz S, Ertl G, Weidemann F, Nordbeck P.

Circ Cardiovasc Imaging. 2018 Aug;11(8):e007131. doi: 10.1161/CIRCIMAGING.117.007131.

PMID:
30354492
9.

Value of cardiac biomarker measurement in the differential diagnosis of infiltrative cardiomyopathy patients with preserved left ventricular systolic function.

Hu K, Liu D, Salinger T, Oder D, Knop S, Ertl G, Weidemann F, Frantz S, Störk S, Nordbeck P.

J Thorac Dis. 2018 Aug;10(8):4966-4975. doi: 10.21037/jtd.2018.07.56.

10.

Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction.

Liu D, Hu K, Liebner E, Weidemann F, Herrmann S, Ertl G, Frantz S, Nordbeck P.

Int J Cardiovasc Imaging. 2018 Dec;34(12):1877-1887. doi: 10.1007/s10554-018-1416-z. Epub 2018 Jul 23.

11.

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease.

Liu D, Oder D, Salinger T, Hu K, Müntze J, Weidemann F, Herrmann S, Ertl G, Wanner C, Frantz S, Störk S, Nordbeck P.

Open Heart. 2018 Jul 12;5(2):e000803. doi: 10.1136/openhrt-2018-000803. eCollection 2018.

12.

European expert consensus statement on therapeutic goals in Fabry disease.

Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, Germain DP, Hughes DA, Jovanovic A, Kantola I, Linhart A, Mignani R, Monserrat L, Namdar M, Nowak A, Oliveira JP, Ortiz A, Pieroni M, Spada M, Tylki-Szymańska A, Tøndel C, Viana-Baptista M, Weidemann F, Hilz MJ.

Mol Genet Metab. 2018 Jul;124(3):189-203. doi: 10.1016/j.ymgme.2018.06.004. Epub 2018 Jun 12. Review.

PMID:
30017653
13.

Group B Streptococci: Declining Incidence in Infants in Germany.

Wicker E, Lander F, Weidemann F, Hufnagel M, Berner R, Krause G.

Pediatr Infect Dis J. 2019 May;38(5):516-519. doi: 10.1097/INF.0000000000002115.

PMID:
29846301
14.

Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.

Liu D, Hu K, Schmidt M, Müntze J, Maniuc O, Gensler D, Oder D, Salinger T, Weidemann F, Ertl G, Frantz S, Wanner C, Nordbeck P.

Clin Res Cardiol. 2018 Dec;107(12):1111-1121. doi: 10.1007/s00392-018-1285-4. Epub 2018 May 24.

15.

Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study.

Oder D, Liu D, Üçeyler N, Sommer C, Hu K, Salinger T, Müntze J, Petritsch B, Ertl G, Wanner C, Nordbeck P, Weidemann F.

Medicine (Baltimore). 2018 May;97(21):e10669. doi: 10.1097/MD.0000000000010669.

16.

Fabry disease revisited: Management and treatment recommendations for adult patients.

Ortiz A, Germain DP, Desnick RJ, Politei J, Mauer M, Burlina A, Eng C, Hopkin RJ, Laney D, Linhart A, Waldek S, Wallace E, Weidemann F, Wilcox WR.

Mol Genet Metab. 2018 Apr;123(4):416-427. doi: 10.1016/j.ymgme.2018.02.014. Epub 2018 Feb 28. Review.

17.

Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.

Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Karch A, Mikolajczyk RT.

BMC Med. 2018 Jan 9;16(1):3. doi: 10.1186/s12916-017-0983-5.

18.

Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF.

Cowie MR, Woehrle H, Wegscheider K, Vettorazzi E, Lezius S, Koenig W, Weidemann F, Smith G, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H.

Eur J Heart Fail. 2018 Mar;20(3):536-544. doi: 10.1002/ejhf.1048. Epub 2017 Nov 30.

19.

Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosages.

Krämer J, Lenders M, Canaan-Kühl S, Nordbeck P, Üçeyler N, Blaschke D, Duning T, Reiermann S, Stypmann J, Brand SM, Gottschling T, Störk S, Wanner C, Sommer C, Brand E, Weidemann F.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1362-1372. doi: 10.1093/ndt/gfx319.

PMID:
29186537
20.

Analysing published global Ebola Virus Disease research using social network analysis.

Hagel C, Weidemann F, Gauch S, Edwards S, Tinnemann P.

PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005747. doi: 10.1371/journal.pntd.0005747. eCollection 2017 Oct.

21.

Extent of size, shape and systolic variability of the left ventricular outflow tract in aortic stenosis determined by phase-contrast MRI.

Sagmeister F, Weininger M, Herrmann S, Bernhardt P, Rasche V, Bauernschmitt R, Liebold A, Köstler H, Weidemann F, Beer M.

Magn Reson Imaging. 2018 Jan;45:58-65. doi: 10.1016/j.mri.2017.09.002. Epub 2017 Sep 5.

PMID:
28887207
22.

Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy.

Yogasundaram H, Kim D, Oudit O, Thompson RB, Weidemann F, Oudit GY.

Can J Cardiol. 2017 Jul;33(7):883-897. doi: 10.1016/j.cjca.2017.04.015. Epub 2017 May 4. Review.

PMID:
28668140
23.

Role of Global Longitudinal Strain in the Prediction of Outcome in Patients With Severe Aortic Valve Stenosis.

Fries B, Liu D, Gaudron P, Hu K, Nordbeck P, Ertl G, Weidemann F, Herrmann S.

Am J Cardiol. 2017 Aug 15;120(4):640-647. doi: 10.1016/j.amjcard.2017.05.032. Epub 2017 May 30.

PMID:
28648391
24.

Biomarkers for Diagnosing and Staging of Fabry Disease.

Kramer J, Weidemann F.

Curr Med Chem. 2018;25(13):1530-1537. doi: 10.2174/0929867324666170616102112. Review.

PMID:
28618999
25.

Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry.

Wilcox WR, Feldt-Rasmussen U, Martins AM, Ortiz A, Lemay RM, Jovanovic A, Germain DP, Varas C, Nicholls K, Weidemann F, Hopkin RJ.

JIMD Rep. 2018;38:45-51. doi: 10.1007/8904_2017_28. Epub 2017 May 17.

26.

Is the impact of childhood influenza vaccination less than expected: a transmission modelling study.

Weidemann F, Remschmidt C, Buda S, Buchholz U, Ultsch B, Wichmann O.

BMC Infect Dis. 2017 Apr 11;17(1):258. doi: 10.1186/s12879-017-2344-6.

27.

[The Fabry's Disease Cardiomyopathy as Differential Diagnosis of Acute Coronary Syndrome].

Oder D, Störk S, Wanner C, Ertl G, Weidemann F, Nordbeck P.

Dtsch Med Wochenschr. 2017 Mar;142(6):442-449. doi: 10.1055/s-0042-118303. Epub 2017 Mar 22. Review. German.

PMID:
28329906
28.

Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis.

Liu D, Hu K, Herrmann S, Cikes M, Ertl G, Weidemann F, Störk S, Nordbeck P.

Int J Cardiovasc Imaging. 2017 Jun;33(6):837-845. doi: 10.1007/s10554-017-1075-5. Epub 2017 Mar 6.

29.

Patent Foramen Ovale and Cryptogenic Strokes in the Stroke in Young Fabry Patients Study.

Huber R, Grittner U, Weidemann F, Thijs V, Tanislav C, Enzinger C, Fazekas F, Wolf M, Hennerici MG, McCabe DJ, Putaala J, Tatlisumak T, Kessler C, von Sarnowski B, Martus P, Kolodny E, Norrving B, Rolfs A; Stroke in Young Fabry Patients (SIFAP) Investigators.

Stroke. 2017 Jan;48(1):30-35. doi: 10.1161/STROKEAHA.116.013620. Epub 2016 Nov 29.

PMID:
27899752
30.

Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid Regurgitation.

Hu K, Liu D, Störk S, Herrmann S, Oder D, Ertl G, Voelker W, Weidemann F, Nordbeck P.

J Card Fail. 2017 Jun;23(6):434-443. doi: 10.1016/j.cardfail.2016.11.005. Epub 2016 Nov 24.

31.

Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease.

Üçeyler N, Schröter N, Kafke W, Kramer D, Wanner C, Weidemann F, Sommer C.

PLoS One. 2016 Nov 16;11(11):e0166484. doi: 10.1371/journal.pone.0166484. eCollection 2016.

32.

Myocardial lipid content in Fabry disease: a combined 1H-MR spectroscopy and MR imaging study at 3 Tesla.

Petritsch B, Köstler H, Weng AM, Horn M, Gassenmaier T, Kunz AS, Weidemann F, Wanner C, Bley TA, Beer M.

BMC Cardiovasc Disord. 2016 Oct 28;16(1):205.

33.

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease.

Lenders M, Hennermann JB, Kurschat C, Rolfs A, Canaan-Kühl S, Sommer C, Üçeyler N, Kampmann C, Karabul N, Giese AK, Duning T, Stypmann J, Krämer J, Weidemann F, Brand SM, Wanner C, Brand E.

Orphanet J Rare Dis. 2016 Jun 29;11(1):88. doi: 10.1186/s13023-016-0473-4.

34.

Systematic Echocardiographic Evaluation of Mitral Valve Regurgitation for Transcatheter Edge-to-Edge Repair.

Wallenborn J, Herrmann S, Hansen M, Hu K, Voelker W, Störk S, Ertl G, Weidemann F.

Echocardiography. 2016 Jul;33(7):1069-79. doi: 10.1111/echo.13251. Epub 2016 Jun 27. Review.

PMID:
27350253
35.

Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.

Weidemann F, Maier SK, Störk S, Brunner T, Liu D, Hu K, Seydelmann N, Schneider A, Becher J, Canan-Kühl S, Blaschke D, Bijnens B, Ertl G, Wanner C, Nordbeck P.

Am J Cardiol. 2016 Jul 15;118(2):264-74. doi: 10.1016/j.amjcard.2016.04.033. Epub 2016 May 5.

36.

High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease.

Seydelmann N, Liu D, Krämer J, Drechsler C, Hu K, Nordbeck P, Schneider A, Störk S, Bijnens B, Ertl G, Wanner C, Weidemann F.

J Am Heart Assoc. 2016 May 31;5(6). pii: e002839. doi: 10.1161/JAHA.115.002839. Erratum in: J Am Heart Assoc. 2016;5(9). pii: e002114. doi: 10.1161/JAHA.116.002114.

37.

Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy.

Liu D, Hu K, Nordbeck P, Ertl G, Störk S, Weidemann F.

Eur J Med Res. 2016 May 10;21(1):21. doi: 10.1186/s40001-016-0216-y. Review.

38.

Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant.

Lenders M, Weidemann F, Kurschat C, Canaan-Kühl S, Duning T, Stypmann J, Schmitz B, Reiermann S, Krämer J, Blaschke D, Wanner C, Brand SM, Brand E.

Orphanet J Rare Dis. 2016 May 4;11(1):54. doi: 10.1186/s13023-016-0441-z.

39.

Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero(®) to reduce meningococcal group B disease in Germany.

Christensen H, Irving T, Koch J, Trotter CL, Ultsch B, Weidemann F, Wichmann O, Hellenbrand W.

Vaccine. 2016 Jun 17;34(29):3412-9. doi: 10.1016/j.vaccine.2016.04.004. Epub 2016 Apr 22.

40.

Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip).

Wallenborn J, Störk S, Herrmann S, Kukuy O, Fette G, Puppe F, Gorski A, Hu K, Voelker W, Ertl G, Weidemann F.

Clin Res Cardiol. 2016 Aug;105(8):699-709. doi: 10.1007/s00392-016-0975-z. Epub 2016 Feb 26.

PMID:
26916650
41.

Long noncoding RNA Chast promotes cardiac remodeling.

Viereck J, Kumarswamy R, Foinquinos A, Xiao K, Avramopoulos P, Kunz M, Dittrich M, Maetzig T, Zimmer K, Remke J, Just A, Fendrich J, Scherf K, Bolesani E, Schambach A, Weidemann F, Zweigerdt R, de Windt LJ, Engelhardt S, Dandekar T, Batkai S, Thum T.

Sci Transl Med. 2016 Feb 17;8(326):326ra22. doi: 10.1126/scitranslmed.aaf1475.

PMID:
26888430
42.

The septal bulge--an early echocardiographic sign in hypertensive heart disease.

Gaudron PD, Liu D, Scholz F, Hu K, Florescu C, Herrmann S, Bijnens B, Ertl G, Störk S, Weidemann F.

J Am Soc Hypertens. 2016 Jan;10(1):70-80. doi: 10.1016/j.jash.2015.11.006. Epub 2015 Dec 2.

43.

Erratum: Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy.

Schmid E, Neef S, Berlin C, Tomasovic A, Kahlert K, Nordbeck P, Deiss K, Denzinger S, Herrmann S, Wettwer E, Weidendorfer M, Becker D, Schäfer F, Wagner N, Ergün S, Schmitt JP, Katus HA, Weidemann F, Ravens U, Maack C, Hein L, Ertl G, Müller OJ, Maier LS, Lohse MJ, Lorenz K.

Nat Med. 2016 Feb;22(2):217. doi: 10.1038/nm0216-217c. No abstract available.

PMID:
26845407
44.

Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1766-76. doi: 10.1080/21645515.2015.1135279. Epub 2016 Feb 2.

45.

Thrombus-in-Transit Following Watchman Device Implantation.

Wallenborn J, Weidemann F, Lengenfelder B, Ritter O, Voelker W.

Echocardiography. 2016 May;33(5):788-791. doi: 10.1111/echo.13172. Epub 2016 Jan 27.

PMID:
26817966
46.

Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.

Krämer J, Bijnens B, Störk S, Ritter CO, Liu D, Ertl G, Wanner C, Weidemann F.

PLoS One. 2015 Nov 23;10(11):e0140627. doi: 10.1371/journal.pone.0140627. eCollection 2015.

47.

Strain Analysis by Tissue Doppler Imaging: Comparison of Conventional Manual Measurement with a Semiautomated Approach.

Schmid J, Kaufmann R, Grübler MR, Verheyen N, Weidemann F, Binder JS.

Echocardiography. 2016 Mar;33(3):372-8. doi: 10.1111/echo.13100. Epub 2015 Oct 30.

PMID:
26515731
48.

Electrical Changes in Resting, Exercise, and Holter Electrocardiography in Fabry Cardiomyopathy.

Krämer J, Nordbeck P, Störk S, Ritter C, Ertl G, Wanner C, Weidemann F.

JIMD Rep. 2015 Oct 27. [Epub ahead of print]

49.

Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy.

Schmid E, Neef S, Berlin C, Tomasovic A, Kahlert K, Nordbeck P, Deiss K, Denzinger S, Herrmann S, Wettwer E, Weidendorfer M, Becker D, Schäfer F, Wagner N, Ergün S, Schmitt JP, Katus HA, Weidemann F, Ravens U, Maack C, Hein L, Ertl G, Müller OJ, Maier LS, Lohse MJ, Lorenz K.

Nat Med. 2015 Nov;21(11):1298-306. doi: 10.1038/nm.3972. Epub 2015 Oct 19. Erratum in: Nat Med. 2016 Feb;22(2):217.

PMID:
26479924
50.

Differences in natural history of low- and high-gradient aortic stenosis from nonsevere to severe stage of the disease.

Herrmann S, Fries B, Liu D, Hu K, Stoerk S, Voelker W, Ruppert C, Lorenz K, Ertl G, Weidemann F.

J Am Soc Echocardiogr. 2015 Nov;28(11):1270-1282.e4. doi: 10.1016/j.echo.2015.07.016. Epub 2015 Aug 28.

PMID:
26321001

Supplemental Content

Loading ...
Support Center